Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
(Thomson Reuters ONE) -
PLAINSBORO, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences
Holdings Corporation (NASDAQ:IART) today announced that it is holding its second
International Symposium on Tissue Technologies in Berlin, Germany on June 15 -
16, 2017.
Following the success of the first International Tissue Technologies Symposium
in 2016, Integra is holding a second event, offering a two-day scientific
symposium, which will bring together more than 100 surgeons from Europe and the
United States. The 2017 International Symposium on Tissue Technologies will
present an overview of different surgical techniques used in various medical
fields, such as dermal reconstruction and regeneration, and plastic and
reconstructive procedures in breast and complex abdominal wall repair. A faculty
of world-renowned key opinion leaders will join the meeting to share their
experience and viewpoints during the different scientific sessions and
discussions.
"As a world leader in regenerative technologies, Integra is committed to
offering a best-in-class medical education platform that will enable physicians
to benefit from the experience of some of the world's leading plastic and
reconstructive surgeons," said Stephane Corp, Integra's vice president, Tissue
Technologies, Europe.
"We share with many surgeons a strong vision of all the scientific benefits
brought by the soft tissue repair technologies. We believe that these
technologies will continue to help improve patients' lives, and we are proud to
offer a forum where practitioners can share best practices and techniques
learned from their personal experience with patients."
About Integra
Integra LifeSciences is dedicated to limiting uncertainty for clinicians, so
they can concentrate on providing the best patient care. Integra offers
innovative solutions, including leading plastic and regenerative technologies,
in specialty surgical solutions, and orthopedics and tissue technologies. For
more information, please visit www.integralife.com.
This news release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 2016. Forward-looking statements
include, but are not limited to, statements concerning the products and services
provided by Integra. Such forward looking statements involve risks and
uncertainties that could cause actual results to differ materially from
predicted or expected results. Among other things, the willingness of surgical
professionals to use Integra products may affect the prospects for their use in
surgical procedures. In addition, the economic, competitive, governmental,
technological and other factors, identified under the heading "Risk Factors"
included in Item IA of Integra's Annual Report on Form 10-K for the year ended
December 31, 2016 and information contained in subsequent filings with the
Securities and Exchange Commission could affect actual results.
Contact Information:
Media:
Marie-Anne Girel (Europe)
+33 4 37 47 59 70
marie-anne.girel(at)integralife.com
Laurene Isip (U.S.)
+ 609 750 7984
laurene.isip(at)integralife.com
Investors:
Michael Beaulieu
+ 1 609 750 2827
michael.beaulieu(at)integralife.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Integra LifeSciences Holdings Corp. via GlobeNewswire
Datum: 15.06.2017 - 09:00 Uhr
Sprache: Deutsch
News-ID 548052
Anzahl Zeichen: 4002
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 404 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany"
steht unter der journalistisch-redaktionellen Verantwortung von
Integra LifeSciences Holdings Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
